Agreed on this, particularly if they continue to get ambiguous results that don't get the market excited, but would still provide sufficent incentive to a larger company
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025